Voters in Florida approved expanded medical cannabis legalization nearly four years ago after failing to do so in 2014, with 71% voting in favor of Amendment 2. The program has...
After soaring nearly 35% in May, the American Cannabis Operator Index pulled back in June, decreasing 9.8% to 27.25: The index, which launched at the end of October 2018 with a...
Following up on the theme we discussed in this weekend’s newsletter regarding our view that a “third wave” in cannabis investing has commenced, we published an extensive review of...
Curaleaf Reports Record First Quarter 2020 Financial and Operational Results Reported Record Pro Forma Revenue(1)(2) of $147.4 Million and Managed Revenue(1) of $105.0 Million; Generated $20.0 Million of Record...
The cannabis sector has evolved substantially since I began following it 7 years ago, but the COVID-19 crisis has made it as challenging as ever to navigate. I created...
Although just two years old, Pennsylvania’s medical cannabis market is booming. The program serves around 160,000 patients, and according to numerous statewide media accounts, there are persistent product shortages,...
The Public Cannabis Company Revenue & Income Tracker, managed by New Cannabis Ventures, ranks the top revenue producing cannabis stocks that generate industry sales of more than US$7.5 million per...
The American Cannabis Operator Index fell again for the tenth consecutive month, declining 9.4% to 39.22, it’s lowest close since inception: During Q4, the index had fared better than the broader...
You’re reading a copy of this week’s edition of the free New Cannabis Ventures weekly newsletter, which we have been publishing since October 2015. Sign up to receive a copy...
After beginning the year with a 57.4% gain in Q1, the Global Cannabis Stock Index moved sharply lower again in November, its eighth consecutive monthly decline, as it lost 12.0% to...
The Public Cannabis Company Revenue Tracker, managed by New Cannabis Ventures, ranks the top revenue producing cannabis stocks that generate industry sales of more than US$5.0 million per quarter. This...
Curaleaf Reports Second Quarter 2019 Financial and Operational Results Reported Record Pro Forma Revenue¹ ² of $110.9 million and Managed Revenue¹ of $55.1 Million Generated $3.4 million of Adjusted...
